395 results on '"Kullberg, Bart-Jan"'
Search Results
2. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications
3. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
4. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study
5. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
6. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
7. Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections
8. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study
9. Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease
10. Lyme borreliosis : diagnosis and management
11. Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
12. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris
13. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis
14. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
15. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
16. Human TLR10 is an anti-inflammatory pattern-recognition receptor
17. Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study.
18. Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital
19. Reply to Anaissie and Nucci and to Cisneros et al
20. Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
21. Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
22. Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study
23. Genetic Variation in the Dectin-1/CARD9 Recognition Pathway and Susceptibility to Candidemia
24. Ocular Manifestations of Candidemia
25. Reply to Kontoyiannis
26. The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis
27. 1,25-dihydroxyvitamin D₃ Modulates Cytokine Production Induced by Candida albicans: Impact of Seasonal Variation of Immune Responses
28. Early Proinflammatory Cytokines and C-Reactive Protein Trends as Predictors of Outcome in Invasive Aspergillosis
29. Recognition of Borrelia burgdorferi by NOD2 Is Central for the Induction of an Inflammatory Reaction
30. Reactive Oxygen Species-Independent Activation of the IL-1β Inflammasome in Cells from Patients with Chronic Granulomatous Disease
31. Early Stop Polymorphism in Human DECTIN-1 Is Associated with Increased Candida Colonization in Hematopoietic Stem Cell Transplant Recipients
32. Reply to Kontoyiannis
33. Functional and Genetic Evidence That the Mal/TIRAP Allele Variant 180L Has Been Selected by Providing Protection against Septic Shock
34. Bypassing Pathogen-Induced Inflammasome Activation for the Regulation of Interleukin-1β Production by the Fungal Pathogen Candida albicans
35. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
36. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
37. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
38. Immune Recognition of Candida albicans β-Glucan by Dectin-1
39. TLR4 Polymorphisms, Infectious Diseases, and Evolutionary Pressure during Migration of Modern Humans
40. Effect of Optimized Antibiotic Prophylaxis on the Incidence of Surgical Site Infection
41. Endogenous Interleukin (IL)-1α and IL-1β Are Crucial for Host Defense against Disseminated Candidiasis
42. Lymeziekte: valkuilen en misverstanden
43. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.
44. C[X.sub.3]CR1-dependent renal macrophage survival promotes Candida control and host survival
45. Recombinant Interleukin-18 Protects against Disseminated Candida Albicans Infection in Mice
46. The role of nurses in the recognition and treatment of patients with sepsis in the emergency department: A prospective before-and-after intervention study
47. Severe Candida spp. infections: new insights into natural immunity
48. The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
49. Aspergillus fumigatus Evades Immune Recognition during Germination through Loss of Toll-Like Receptor-4-Mediated Signal Transduction
50. Delayed Clearance of Intraabdominal Abscesses Caused by Candida albicans in Tumor Necrosis Factor-α- and Lymphotoxin-a-Deficient Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.